For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Agilon Health Inc (NYSE: AGL) closed at $2.39 in the last session, up 0.42% from day before closing price of $2.38. In other words, the price has increased by $0.42 from its previous closing price. On the day, 4.36 million shares were traded. AGL stock price reached its highest trading level at $2.39 during the session, while it also had its lowest trading level at $2.25.
Ratios:
We take a closer look at AGL’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.20 and its Current Ratio is at 1.20. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.01.
On April 08, 2025, Bernstein Upgraded its rating to Outperform which previously was Mkt Perform but kept the price unchanged to $8.50.
Citigroup Upgraded its Sell to Neutral on January 10, 2025, whereas the target price for the stock was revised from $1.75 to $2.25.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 13 ’24 when McLoughlin Karen bought 25,000 shares for $2.20 per share. The transaction valued at 55,085 led to the insider holds 73,166 shares of the business.
Battaglia Silvana bought 25,062 shares of AGL for $50,269 on Dec 11 ’24. The Director now owns 66,144 shares after completing the transaction at $2.01 per share. On Nov 25 ’24, another insider, MCKENZIE DIANA, who serves as the Director of the company, bought 12,500 shares for $2.28 each. As a result, the insider paid 28,474 and bolstered with 51,319 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AGL now has a Market Capitalization of 989345344 and an Enterprise Value of 627024064. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.17 while its Price-to-Book (P/B) ratio in mrq is 1.97. Its current Enterprise Value per Revenue stands at 0.105 whereas that against EBITDA is -2.278.
Stock Price History:
The Beta on a monthly basis for AGL is 0.16, which has changed by -0.5989933 over the last 52 weeks, in comparison to a change of 0.1185931 over the same period for the S&P500. Over the past 52 weeks, AGL has reached a high of $7.73, while it has fallen to a 52-week low of $1.50. The 50-Day Moving Average of the stock is -12.56%, while the 200-Day Moving Average is calculated to be -21.88%.
Shares Statistics:
According to the various share statistics, AGL traded on average about 5.23M shares per day over the past 3-months and 3331190 shares per day over the past 10 days. A total of 413.02M shares are outstanding, with a floating share count of 302.33M. Insiders hold about 26.96% of the company’s shares, while institutions hold 73.52% stake in the company. Shares short for AGL as of 1749772800 were 21228626 with a Short Ratio of 4.06, compared to 1747267200 on 22198808. Therefore, it implies a Short% of Shares Outstanding of 21228626 and a Short% of Float of 8.3900005.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
